205 related articles for article (PubMed ID: 8672997)
1. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
Klabunde C; Kaluzny A; Ford L
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
[TBL] [Abstract][Full Text] [Related]
2. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
[TBL] [Abstract][Full Text] [Related]
3. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
Lacey LM; Hynes DM; Kaluzny AD
J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
[TBL] [Abstract][Full Text] [Related]
4. The effects of managed care and competition on community-based clinical research.
Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
[TBL] [Abstract][Full Text] [Related]
5. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
Kaluzny AD; Lacey LM; Warnecke R; Morrissey JP; Sondik E; Ford L
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377
[TBL] [Abstract][Full Text] [Related]
6. Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.
Lyss AP; Lilenbaum RC
Clin Lung Cancer; 2009 Nov; 10(6):410-3. PubMed ID: 19900858
[TBL] [Abstract][Full Text] [Related]
7. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
McKinney MM; Weiner BJ; Wang V
Oncol Nurs Forum; 2006 Sep; 33(5):951-9. PubMed ID: 16955123
[TBL] [Abstract][Full Text] [Related]
8. Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.
Klabunde CN; Kaluzny AD
Breast Cancer Res Treat; 1995 Jul; 35(1):43-50. PubMed ID: 7612903
[TBL] [Abstract][Full Text] [Related]
9. Changing cancer outcome: the role of LSUMC Minority-Based Clinical Community Oncology Program.
Hayden J; Veith R; Thomas SM; Austin JP; Moore T
J La State Med Soc; 1997 Apr; 149(4):131-3. PubMed ID: 9130816
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
11. Implementing a cancer-control study in a National Cancer Institute clinical trials network.
Labuhn KT; Valanis BG; Glass AG; Vollmer WM
Cancer Pract; 1994; 2(1):47-54. PubMed ID: 8055006
[TBL] [Abstract][Full Text] [Related]
12. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
[TBL] [Abstract][Full Text] [Related]
13. A research nurse: enhancing participation in clinical trials.
O'Halloran LJ; Curl VR; Hagen L; Sveningson L
Prog Clin Biol Res; 1989; 293():355-60. PubMed ID: 2726947
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer prevention in community clinics: will low-income Latina patients participate in clinical trials?
Mandelblatt J; Kaufman E; Sheppard VB; Pomeroy J; Kavanaugh J; Canar J; Pallandre L; Cullen J; Huerta E
Prev Med; 2005 Jun; 40(6):611-8. PubMed ID: 15850856
[TBL] [Abstract][Full Text] [Related]
15. Organizations and structures that facilitate community research.
Coltman CA
Semin Oncol; 1994 Aug; 21(4 Suppl 7):107-11. PubMed ID: 8091235
[TBL] [Abstract][Full Text] [Related]
16. Cancer control research for community programs: the National Cancer Institute initiative.
Hunter CP; Bavier AR; Ford LG
Cancer Detect Prev; 1990; 14(6):633-7. PubMed ID: 2257561
[TBL] [Abstract][Full Text] [Related]
17. Prevention of breast cancer in high-risk women.
Kardinal CG; Veith R
J La State Med Soc; 1999 Apr; 151(4):198-201. PubMed ID: 10234895
[TBL] [Abstract][Full Text] [Related]
18. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
19. The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.
Stanton AL; Bernaards CA; Ganz PA
J Natl Cancer Inst; 2005 Mar; 97(6):448-56. PubMed ID: 15770009
[TBL] [Abstract][Full Text] [Related]
20. Surgeons: A Future Role in Clinical Trials?
Rusch VW
Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
